Parabilis Medicines, Inc. Common Stock (PBLS)
PHARMACEUTICAL PREPARATIONS
Parabilis Medicines, Inc. Common Stock (PBLS) is listed on Nasdaq, where it has traded since June 10, 2026.
- Listed On
- Nasdaq
- Listed Since
- June 10, 2026
- Market Cap
- $4.0B
About Parabilis Medicines, Inc. Common Stock
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 76 institutions reported holding PBLS, with 99.0 million shares worth $2.7 billion in aggregate. The largest reported holder was RA Capital Management,, with 28.9 million shares worth $791.9 million. Of the 5 largest holders listed below, all 5 opened new positions in PBLS during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| RA Capital Management, | 28,933,371 | $792M | New position |
| FMR | 10,292,735 | $282M | New position |
| Arch Venture Management | 6,412,780 | $176M | New position |
| Venbio Partners | 5,266,697 | $144M | New position |
| Alphabet | 4,919,498 | $135M | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is PBLS?
Parabilis Medicines, Inc. Common Stock (PBLS) is listed on Nasdaq, where it has traded since June 10, 2026.
Who are the largest institutional holders of PBLS?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of PBLS were RA Capital Management,, FMR and Arch Venture Management.
How many institutions own PBLS?
76 institutions reported a position in PBLS for the quarter ended June 30, 2026, worth $2.7 billion in total.
Did institutions buy or sell PBLS last quarter?
Of the 5 largest reported holders, all 5 opened new positions in PBLS during the quarter. Every reported holder and its change is on the SentiSense ownership page for PBLS.
Every reported institutional holder, plus insider and congressional trades in PBLS, on SentiSense.